AZN

New York Stock Exchange

AstraZeneca PLC · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$282.04B

PE Ratio

57.1459

EV to Ebitda

16.2471

Earnings Yield

1.75%

Revenue (TTM)

$58.80B

Net Income (TTM)

$10.24B

Revenue (Annual YoY Growth)

8.84%

Revenue (Quarterly YoY Growth)

4.93%

Profit Margin

17.42%

Return on Equity

23.12%

Debt to Equity Ratio

0.6087

Dividend Yield

1.77%

All fundamentals

Core10 fields›

Market Cap$282.04B

Revenue TTM$58.80B

Shares Outstanding1.55B

Float1544353000

Float Short0.11%

Days To Cover0.9134440745

Short Interest1725297.0

Institutional Ownership42.32%

Relative Strength37.2

GARP508

Growth Estimates19 fields›

Revenue Growth (Annual)8.84%

Revenue Growth (Quarterly YoY)4.93%

Operating Revenue Growth (Annual)0.172767

Operating Revenue Growth (Quarterly YoY)0.126585

3-Year Revenue Growth9.90%

5-Year Revenue Growth16.37%

EPS Growth (Annual)45.72%

EPS Growth (Quarterly YoY)56.19%

3-Year EPS Growth Rate46.02%

5-Year EPS Growth Rate21.93%

LT EPS Growth Estimates9.00%

EBITDA Growth (Annual)9.42%

EBITDA Growth (Quarterly YoY)2.45%

CFO Growth (Annual)22.00%

CFO Growth (Quarterly YoY)-19.00%

FCF Growth (Annual)17.79%

FCF Growth (Quarterly YoY)-44.35%

Dividend Growth (Annual)-66.78%

Dividend Growth (Quarterly YoY)-100.00%

Operations28 fields›

Revenue TTM$58.80B

Gross Margin TTM74.36%

Gross Margin (Quarterly)72.19%

R&D % of Revenue TTM23.54%

R&D Expenses TTM$13.84B

Operating Margin TTM23.16%

Operating Margin (Quarterly)18.93%

Operating Expenses TTM$30.10B

Profit Margin TTM17.42%

Profit Margin (Quarterly)15.02%

Net Income TTM$10.24B

EPS TTM3.2788

EPS (Quarterly)0.743

EBIT Margin TTM23.16%

EBIT Margin (Quarterly)18.93%

EBITDA Margin TTM32.92%

EBITDA Margin (Quarterly)28.67%

EBITDA TTM$19.36B

CFO % of Revenue TTM25.30%

CFO % of Revenue (Quarterly)15.53%

CFO TTM$14.90B

Cash Margin15.30%

Capex % of Revenue TTM10.07%

Capital Expenditures$5.92B

FCF % of Revenue TTM15.25%

FCF % of Revenue (Quarterly)7.24%

FCF TTM$8.98B

Fundamental Score9

Efficiency5 fields›

ROE23.12%

ROA9.29%

ROIC13.53%

CROCI11.86%

Stock Comp % TTM1.22%

Valuation19 fields›

P/E (TTM)57.1459

P/E Ex-Cash56.0169

P/S Forward4.5858

PEG1.2482

P/CFO39.2709

P/FCF65.1636

EV/EBITDA (TTM)16.2471

EV/EBITDA Forward14.0909

EV/Revenues (TTM)5.3488

EV/Revenues Forward4.9635

EV/CFO20.7479

EV/FCF (TTM)35.0357

Price To Book5.9708

Price to Tangible Book-8.2441

Earnings Yield1.75%

FCF Yield1.53%

Dividend Yield1.77%

Payout Ratio0.00%

Value Score4

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.0151

Relative Profit Margin (Quarterly)1.1414

Relative P/E2.3267

Relative P/S2.1134

Relative P/B0.9441

Relative Earnings Yield0.4298

Relative Dividend Yield0.4933

Relative ROE0.7823

Relative ROA0.9629

Relative ROIC0.9189

Relative Debt to Equity0.6162

Liquidity15 fields›

Cash Per Share1.851

Current Ratio0.9381

Cash & ST Assets$5.74B

Total Debt$28.97B

Goodwill & Intangibles$59.09B

Total Assets$114.07B

Total Liabilities$65.30B

Shareholders Equity$48.67B

Debt to Equity0.6087

Debt to Assets25.97%

Interest Expense$1.71B

Times Interest Earned7.974

CFO to Debt (TTM)0.4743

Debt to EBITDA (TTM)1.6224

Goodwill % of Assets51.80%

Yields5 fields›

Dividend Yield1.77%

Payout Ratio0.00%

Earnings Yield1.75%

Buyback Yield0.23%

Shareholder Yield2.07%

Options Flow8 fields›

Call Volume426

Put Volume49

Put/Call Ratio0.11502347417840375

Call $ Volume169827

Put $ Volume40971

Put/Call $ Ratio0.2412513911215531

Call OI23444

Put OI26309